Language
English
Publication Date
4-1-2024
Journal
JACC: Heart Failure
DOI
10.1016/j.jchf.2023.06.009
PMID
37565972
Abstract
Background: Implantable cardioverter-defibrillator (ICD) therapy is recommended to reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF). Frailty is common among patients with HFrEF and is associated with increased mortality risk. Whether the therapeutic efficacy of ICD is consistent among frail and nonfrail patients with HFrEF remains unclear.
Objectives: The aim of this study was to evaluate the effect modification of baseline frailty burden on ICD efficacy for primary prevention among participants of the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
Methods: Participants in SCD-HeFT with HFrEF randomized to ICD vs placebo were included. Baseline frailty was estimated using the Rockwood Frailty Index (FI), and participants were stratified into high (FI > median) vs low (FI ≤ median) frailty burden groups. Multivariable Cox models with multiplicative interaction terms (frailty × treatment arm) were constructed to evaluate whether baseline frailty status modified the treatment effect of ICD for all-cause mortality.
Results: The study included 1,676 participants (mean age: 59 ± 12 years, 23% women) with a median FI of 0.30 (IQR: 0.23-0.37) in the low frailty group and 0.54 (IQR: 0.47-0.60) in the high frailty group. In adjusted Cox models, baseline frailty status significantly modified the treatment effect of ICD therapy (Pinteraction = 0.047). In separate stratified analysis by frailty status, ICD therapy was associated with a lower risk of all-cause mortality among participants with low frailty burden (HR: 0.56; 95% CI: 0.40-0.78) but not among those with high frailty burden (HR: 0.86; 95% CI: 0.68-1.09).
Conclusions: Baseline frailty modified the efficacy of ICD therapy with a significant mortality benefit observed among participants with HFrEF and a low frailty burden but not among those with a high frailty burden.
Keywords
Humans, Female, Middle Aged, Aged, Male, Heart Failure, Defibrillators, Implantable, Frailty, Stroke Volume, Primary Prevention, Death, Sudden, Cardiac, Risk Factors, frailty, implantable cardioverter-defibrillator
Published Open-Access
yes
Recommended Citation
Segar, Matthew W; Keshvani, Neil; Singh, Sumitabh; et al., "Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF" (2024). Faculty and Staff Publications. 4172.
https://digitalcommons.library.tmc.edu/baylor_docs/4172